Paul Vigano Sells 1,000,000 Shares of Aveanna Healthcare (NASDAQ:AVAH) Stock

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) major shareholder Paul Vigano sold 1,000,000 shares of the company’s stock in a transaction dated Wednesday, June 24th. The stock was sold at an average price of $8.00, for a total transaction of $8,000,000.00. Following the completion of the transaction, the insider owned 245,251 shares in the company, valued at approximately $1,962,008. The trade was a 80.31% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Major shareholders that own 10% or more of a company’s stock are required to disclose their sales and purchases with the SEC.

Aveanna Healthcare Trading Up 1.5%

AVAH traded up $0.12 on Friday, reaching $8.61. 953,109 shares of the company traded hands, compared to its average volume of 1,436,922. Aveanna Healthcare Holdings Inc. has a one year low of $3.73 and a one year high of $10.32. The firm has a fifty day simple moving average of $7.10 and a two-hundred day simple moving average of $7.57. The company has a market cap of $1.87 billion, a P/E ratio of 7.29, a price-to-earnings-growth ratio of 0.87 and a beta of 1.93. The company has a quick ratio of 1.47, a current ratio of 1.47 and a debt-to-equity ratio of 5.35.

Aveanna Healthcare (NASDAQ:AVAH) last released its quarterly earnings data on Thursday, May 14th. The company reported $0.18 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.13 by $0.05. The company had revenue of $647.91 million during the quarter, compared to analysts’ expectations of $613.22 million. Aveanna Healthcare had a net margin of 10.37% and a return on equity of 124.68%. Aveanna Healthcare’s revenue for the quarter was up 15.9% on a year-over-year basis. As a group, equities research analysts expect that Aveanna Healthcare Holdings Inc. will post 0.65 earnings per share for the current year.

Wall Street Analyst Weigh In

Several research firms have commented on AVAH. Barclays reduced their price objective on Aveanna Healthcare from $9.50 to $9.00 and set an “overweight” rating on the stock in a report on Monday, May 18th. Truist Financial increased their price target on Aveanna Healthcare from $8.00 to $9.00 and gave the stock a “hold” rating in a research report on Wednesday, May 20th. BMO Capital Markets decreased their price objective on Aveanna Healthcare from $11.00 to $10.00 and set an “outperform” rating for the company in a report on Friday, March 20th. Stephens raised shares of Aveanna Healthcare from an “equal weight” rating to an “overweight” rating and upped their price objective for the stock from $10.00 to $11.00 in a research note on Friday, May 15th. Finally, Weiss Ratings cut shares of Aveanna Healthcare from a “buy (b-)” rating to a “hold (c+)” rating in a report on Monday, April 6th. One research analyst has rated the stock with a Strong Buy rating, six have given a Buy rating and five have given a Hold rating to the company. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $10.50.

Institutional Trading of Aveanna Healthcare

Hedge funds and other institutional investors have recently bought and sold shares of the stock. AustralianSuper Pty Ltd bought a new position in shares of Aveanna Healthcare in the 3rd quarter worth $15,743,000. Vanguard Group Inc. boosted its position in Aveanna Healthcare by 38.0% during the fourth quarter. Vanguard Group Inc. now owns 5,577,010 shares of the company’s stock valued at $45,564,000 after purchasing an additional 1,535,351 shares in the last quarter. Algert Global LLC grew its stake in Aveanna Healthcare by 120.1% in the third quarter. Algert Global LLC now owns 1,022,599 shares of the company’s stock valued at $9,070,000 after purchasing an additional 557,898 shares during the last quarter. Quantbot Technologies LP grew its stake in Aveanna Healthcare by 1,220.8% in the third quarter. Quantbot Technologies LP now owns 109,707 shares of the company’s stock valued at $973,000 after purchasing an additional 101,401 shares during the last quarter. Finally, UBS Group AG raised its holdings in Aveanna Healthcare by 149.4% in the fourth quarter. UBS Group AG now owns 394,182 shares of the company’s stock worth $3,220,000 after purchasing an additional 236,152 shares in the last quarter. Institutional investors own 87.96% of the company’s stock.

About Aveanna Healthcare

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.